Nixon Peabody Trust CO Cortexyme, Inc. Transaction History
Nixon Peabody Trust CO
- $1.31 Billion
- Q3 2025
A detailed history of Nixon Peabody Trust CO transactions in Cortexyme, Inc. stock. As of the latest transaction made, Nixon Peabody Trust CO holds 11,126 shares of CRTX stock, worth $14,352. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,126
Previous 11,126
-0.0%
Holding current value
$14,352
Previous $14,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRTX
# of Institutions
50Shares Held
12.6MCall Options Held
98.3KPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT3.07MShares$3.97 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$2.27 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.39MShares$1.79 Million0.0% of portfolio
-
Ieq Capital, LLC981KShares$1.27 Million0.0% of portfolio
-
Epiq Capital Group, LLC San Francisco, CA825KShares$1.06 Million0.31% of portfolio
About Cortexyme, Inc.
- Ticker CRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,150,800
- Market Cap $70.5M